Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data (2014)
- Autores:
- Autor USP: SQUIRE, JEREMY ANDREW - FMRP
- Unidade: FMRP
- Assunto: NEOPLASIAS PROSTÁTICAS
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Abstracts
- Nome do evento: European Human Genetics Conference
-
ABNT
SQUIRE, Jeremy Andrew e GREER, P. e WILLIAMS, J. Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data. 2014, Anais.. Milan: ESHG, 2014. . Acesso em: 25 set. 2024. -
APA
Squire, J. A., Greer, P., & Williams, J. (2014). Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data. In Abstracts. Milan: ESHG. -
NLM
Squire JA, Greer P, Williams J. Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data. Abstracts. 2014 ;[citado 2024 set. 25 ] -
Vancouver
Squire JA, Greer P, Williams J. Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data. Abstracts. 2014 ;[citado 2024 set. 25 ] - Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
- Extracellular vesicles: evolving factors in stem cell biology
- The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation
- In silico shows that PTEN loss and AR overexpression are associated with increased CD8+ T-cell and Treg density and earlier disease recurrence in prostate cancer
- Clinical implications of PTEN loss in prostate cancer
- A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
- First application of the Automated QUantitative Analysis (AQUA) technique to quantify PTEN protein expression in ovarian cancer: a correlative study of NCIC CTG OV.16
- Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
